Results of clinical examinations, laboratory tests, and ultrasonography in dogs with pituitary-dependent hyperadrenocorticism treated with trilostane

American Journal of Veterinary Research

Volumn 63, Issue 4, 2002, Pages 506-512

  Ruckstuhl, Nadja S ^a   Nett, Claudia S ^a   Reusch, Claudia E ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; HYDROCORTISONE; TRILOSTANE;

ADRENAL GLAND; ANIMAL EXPERIMENT; ANIMAL MODEL; ANOREXIA; ARTICLE; BLOOD CELL COUNT; CLINICAL EXAMINATION; CLINICAL FEATURE; CONTROLLED STUDY; CORTICOTROPIN TEST; DOG; DRUG EFFICACY; DRUG RESPONSE; ECHOGRAPHY; HYPERADRENOCORTICISM; HYPOPHYSIS; LABORATORY TEST; LETHARGY; NONHUMAN; ORGAN SIZE; PHYSICAL ACTIVITY; POLYDIPSIA; POLYURIA; SEROLOGY; SKIN;

ANIMALIA; CANIS FAMILIARIS;

EID: 0036213978     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2002.63.506     Document Type: Article

References (26)

1. Therapy for spontaneous canine hyperadrenocorticism
2. Medical treatment of pituitary-dependent hyperadrenocorticism in dogs
3. Hyperadrenocorticism
4. An alternative protocol for the medical management of canine pituitary-dependent hyperadrenocorticism
5. Mitotane (o,p′-DDD) treatment of 200 dogs with pituitary-dependent hyperadrenocorticism
6. Medical management of Cushing's syndrome using o,p′-DDD
7. Results of cyproheptadine treatment in dogs with pituitary-dependent hyperadrenocorticism
8. Pathophysiology of canine pituitary-dependent hyperadrenocorticism (canine Cushing's disease)
9. Effects of bromocriptine on corticotropin, melanotropin, and corticosteroid secretion in dogs with pituitary-dependent hyperadrenocorticism
10. Plasma cortisol response to ketoconazole administration in dogs with hyperadrenocorticism
11. The efficacy of L-deprenyl in dogs with pituitary-dependent hyperadrenocorticism
12. Trilostane, an orally active inhibitor of steroid biosynthesis
13. Treatment of Cushing's syndrome with trilostane (WIN 24,540), an inhibitor of adrenal steroid biosynthesis
14. Long-term treatment of idiopathic hyperaldosteronism using trilostane
15. Experience with trilostane in the treatment of Cushing's syndrome
16. Trilostane in the management of Cushing's syndrome
17. Ultrasonographic characteristics of the adrenal glands in dogs with pituitary-dependent hyperadrenocorticism: Comparison with normal dogs
18. Auswirkungen der Mitotane-Therapie bei Hunden mit hypophysärem Cushing-Syndrom auf die Nebennnierengrösse-eine sonographische Studie
19. Darstellung der Nebennieren mittels Ultraschall: Untersuchungen bei gesunden Hunden, Hunden mit nicht-endokrinen Erkrankungen sowie mit Cushing-Syndrom
20. 24 hour cortisol values after trilostane therapy in dogs with hyperadrenocorticism
21. Laboratory parameters for the control of the course of therapy of canine Cushing's syndrome
22. Effect of o,p′-DDD therapy on endogenous ACTH concentrations in dogs with hypophysis-dependent hyperadrenocorticism
23. On the specifity of the inhibitory effect of trilostane and aminoglutethimide on adrenocortical steroidogenesis in guinea pig
24. Primary aldosteronism treated by trilostane
25. Glucocorticoids and adrenal androgens
26. Mitotane-Behandlung bei einem Hund mit einem rezidivierenden Nebennierenrindenkarzinom-ein Fallbericht